he study is approved by the IRB, the sponsor and investigator must comply with
&quot;abbreviated IDE requirements&quot; [21 CFR 812.2(b)], and informed consent and IRB
regulations [21 CFR parts 50 and 56]. </p>

<p><u>The Decision to Approve or Disapprove</u> </p>

<p>Once the SR/NSR decision has been reached, the IRB should consider whether the study
should be approved or not. The criteria for deciding if SR and NSR studies should be
approved are the same as for any other FDA regulated study [21 CF